Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Tamargo

Showing results (71-80 of 184) with videos related to

Pageof 19
Sort By:
Journal of Molecular and Cellular Cardiology|July 21, 2009
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent mannerIrene Amorós, Adriana Barana, Ricardo Caballero, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 27, 2025
Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitusHeinz Drexel, Andreas Festa, Thomas A Schmidt, et al.
Annals of the New York Academy of Sciences|March 8, 2007
Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteriesAngel Cogolludo, Giovanna Frazziano, Laura Cobeño, et al.
Pharmacological Research|February 16, 2024
An account on the history of pharmacology in SpainAna María Aldea-Perona, Jesús Flórez Beledo, Jesús Frías Iniesta, et al.
Journal of Hypertension|December 7, 2005
Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive ratsManuel Sánchez, Milagros Galisteo, Rocío Vera, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarizationIgnacio Moreno, Ricardo Caballero, Teresa González, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 7, 2026
Management of dyslipidaemia in patients with comorbidities - facing the challenge: Heart failureHeinz Drexel, Matthias Frick, Andreas Zirlik, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active alpha 1D-adrenoceptors in vascular smooth muscleRegina Gisbert, Francisco Pérez-Vizcaino, Angel L Cogolludo, et al.
Atherosclerosis|June 18, 2010
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activationMiguel Romero, Rosario Jiménez, Manuel Sánchez, et al.
Planta Medica|May 4, 2002
Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atriaManuel Ibarra, Francisco Pérez-Vizcaíno, Angel Cogolludo, et al.
Pageof 19

Showing results (71-80 of 184) with videos related to

Sort By:
Pageof 19
Journal of Molecular and Cellular Cardiology|July 21, 2009
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent mannerIrene Amorós, Adriana Barana, Ricardo Caballero, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 27, 2025
Management of dyslipidaemia in patients with comorbidities: facing the challenge: type 2 diabetes mellitusHeinz Drexel, Andreas Festa, Thomas A Schmidt, et al.
Annals of the New York Academy of Sciences|March 8, 2007
Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteriesAngel Cogolludo, Giovanna Frazziano, Laura Cobeño, et al.
Pharmacological Research|February 16, 2024
An account on the history of pharmacology in SpainAna María Aldea-Perona, Jesús Flórez Beledo, Jesús Frías Iniesta, et al.
Journal of Hypertension|December 7, 2005
Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive ratsManuel Sánchez, Milagros Galisteo, Rocío Vera, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
Effects of irbesartan on cloned potassium channels involved in human cardiac repolarizationIgnacio Moreno, Ricardo Caballero, Teresa González, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 7, 2026
Management of dyslipidaemia in patients with comorbidities - facing the challenge: Heart failureHeinz Drexel, Matthias Frick, Andreas Zirlik, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
Cytosolic Ca2+ and phosphoinositide hydrolysis linked to constitutively active alpha 1D-adrenoceptors in vascular smooth muscleRegina Gisbert, Francisco Pérez-Vizcaino, Angel L Cogolludo, et al.
Atherosclerosis|June 18, 2010
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activationMiguel Romero, Rosario Jiménez, Manuel Sánchez, et al.
Planta Medica|May 4, 2002
Cardiovascular effects of isorhamnetin and quercetin in isolated rat and porcine vascular smooth muscle and isolated rat atriaManuel Ibarra, Francisco Pérez-Vizcaíno, Angel Cogolludo, et al.
Pageof 19